Psychotic symptoms in first-episode and drug naïve patients with major depressive disorder: Prevalence and related clinical factors.


Journal

Depression and anxiety
ISSN: 1520-6394
Titre abrégé: Depress Anxiety
Pays: United States
ID NLM: 9708816

Informations de publication

Date de publication:
08 2020
Historique:
received: 13 11 2018
revised: 10 12 2019
accepted: 19 04 2020
pubmed: 10 5 2020
medline: 1 1 2021
entrez: 9 5 2020
Statut: ppublish

Résumé

Many patients with major depressive disorder (MDD) have been found to have psychotic symptoms. However, few studies have reported the prevalence of comorbid psychotic symptoms in first-episode drug naïve (FEDN) MDD patients. This study was to investigate the prevalence of psychotic symptoms and related risk factors in a large sample size of FEDN MDD patients in a Chinese population. A total of 573 patients with diagnosis of MDD at their first episode were recruited with their demographic and clinical data. Positive scale of the Positive and Negative Syndrome Scale was utilized for psychotic symptoms, Hamilton Anxiety Rating Scale (HAMA) for anxiety symptoms, and Hamilton Depression Rating Scale (HAMD) for depressive symptoms. The prevalence of psychotic symptoms in these MDD patients was 9.8%. MDD patients with psychotic symptoms had significantly higher HAMD and HAMA total scores than those without psychotic symptoms (both p < .001). A strong association was found between psychotic MDD and anxiety or suicide, with odds ratio of 33.097 for severe anxiety, and 5.012 for suicide. Our results suggest that psychotic symptoms are common in MDD patients at their first episode. The strong association between psychotic MDD and anxiety or suicide attempts demonstrates the importance of reducing anxiety symptoms in the treatment of psychotic MDD patients as well as the necessity to regularly assess suicide risk in MDD patients with psychotic symptoms to better prevent suicidal behavior.

Sections du résumé

BACKGROUND
Many patients with major depressive disorder (MDD) have been found to have psychotic symptoms. However, few studies have reported the prevalence of comorbid psychotic symptoms in first-episode drug naïve (FEDN) MDD patients. This study was to investigate the prevalence of psychotic symptoms and related risk factors in a large sample size of FEDN MDD patients in a Chinese population.
METHODS
A total of 573 patients with diagnosis of MDD at their first episode were recruited with their demographic and clinical data. Positive scale of the Positive and Negative Syndrome Scale was utilized for psychotic symptoms, Hamilton Anxiety Rating Scale (HAMA) for anxiety symptoms, and Hamilton Depression Rating Scale (HAMD) for depressive symptoms.
RESULTS
The prevalence of psychotic symptoms in these MDD patients was 9.8%. MDD patients with psychotic symptoms had significantly higher HAMD and HAMA total scores than those without psychotic symptoms (both p < .001). A strong association was found between psychotic MDD and anxiety or suicide, with odds ratio of 33.097 for severe anxiety, and 5.012 for suicide.
CONCLUSIONS
Our results suggest that psychotic symptoms are common in MDD patients at their first episode. The strong association between psychotic MDD and anxiety or suicide attempts demonstrates the importance of reducing anxiety symptoms in the treatment of psychotic MDD patients as well as the necessity to regularly assess suicide risk in MDD patients with psychotic symptoms to better prevent suicidal behavior.

Identifiants

pubmed: 32383260
doi: 10.1002/da.23026
doi:

Substances chimiques

Pharmaceutical Preparations 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

793-800

Subventions

Organisme : Suzhou Clinical Medical Expert Team Introduced Project
ID : SZYJTD201715 to XDD
Pays : International
Organisme : Suzhou Key Medical Center for Psychiatric Diseases
ID : Szzx201509 to XDD
Pays : International
Organisme : Natural Science Fund Project of Jiangsu Province
ID : BK20151197 to XDD
Pays : International

Informations de copyright

© 2020 Wiley Periodicals, Inc.

Références

Addington, J., Cornblatt, B. A., Cadenhead, K. S., Cannon, T. D., Mcglashan, T. H., Perkins, D. O., … Woods, S. W. (2011). At clinical high risk for psychosis: Outcome for Nonconverters. American Journal of Psychiatry, 168(8), 800-805.
Aikawa, S., Kobayashi, H., Nemoto, T., Matsuo, S., Wada, Y., Mamiya, N., … Mizuno, M. (2018). Social anxiety and risk factors in patients with schizophrenia: Relationship with duration of untreated psychosis. Psychiatry Research, 263, 94-100.
Association, D.-A. P. (2013). Diagnostic and Statistical Manual of Mental Disorders. Arlington, TX: American Psychiatric Publishing.
Black, D. W., Winokur, G., & Nasrallah, A. (1988). Effect of psychosis on suicide risk in 1,593 patients with unipolar and bipolar affective disorders. American Journal of Psychiatry, 145(7), 849-852.
Brown, R. P., Frances, A., Kocsis, J. H., & Mann, J. J. (1982). Psychotic vs. nonpsychotic depression: Comparison of treatment response. The Journal of Nervous and Mental Disease, 170(10), 635-637.
Buoli, M., Caldiroli, A., & Altamura, A. C. (2013). Psychotic versus non-psychotic major depressive disorder: A comparative naturalistic study. Asian Journal of Psychiatry, 6(4), 333-337.
Coryell, W., Leon, A., Winokur, G., & Endicott, J. (1996). Importance of psychotic features to long-term course in major depressive disorder. The American Journal of Psychiatry, 153(4), 483-489.
Coryell, W., Pfohl, B., & Zimmerman, M. (1984). The clinical and neuroendocrine features of psychotic depression. Journal of Nervous and Mental Disease, 172, 521-528.
Coryell, W., & Tsuang, M. T. (1982). Primary unipolar depression and the prognostic importance of delusions. Archives of General Psychiatry, 39(10), 1181-1184.
Dernovsek, M. Z., & Sprah, L. (2009). Comorbid anxiety in patients with psychosis. Psychiatria Danubina, 21(Suppl 1), 43-50.
DeVylder, J. E., Lukens, E. P., Link, B. G., & Lieberman, J. A. (2015). Suicidal ideation and suicide attempts among adults with psychotic experiences: Data from the Collaborative Psychiatric Epidemiology Surveys. JAMA Psychiatry, 72(3), 219-225.
Ferrari, A. J., Charlson, F. J., Norman, R. E., Flaxman, A. D., Patten, S. B., Vos, T., & Whiteford, H. A. (2013). The epidemiological modelling of major depressive disorder: Application for the Global Burden of Disease Study 2010. PLoS One, 8(7):e69637.
Fredriksen, K. J., Schoeyen, H. K., Johannessen, J. O., Walby, F. A., Davidson, L., & Schaufel, M. A. (2017). Psychotic Depression and Suicidal Behavior. Psychiatry, 80(1), 17-29.
Freeman, D., & Garety, P. A. (1999). Worry, worry processes and dimensions of delusions: An exploratory investigation of a role for anxiety processes in the maintenance of delusional distress. Behavioural and Cognitive Psychotherapy, 27(1), 47-62.
Freeman, D., Garety, P. A., Kuipers, E., Fowler, D., Bebbington, P. E., & Dunn, G. (2007). Acting on persecutory delusions: The importance of safety seeking. Behaviour Research and Therapy, 45(1), 89-99.
Gaudiano, B. A., Dalrymple, K. L., & Zimmerman, M. (2009). Prevalence and clinical characteristics of psychotic versus nonpsychotic major depression in a general psychiatric outpatient clinic. Depression and Anxiety, 26(1), 54-64.
Gaudiano, B. A., & Miller, I. W. (2007). Dysfunctional cognitions in hospitalized patients with psychotic versus nonpsychotic major depression. Comprehensive Psychiatry, 48(4), 357-365.
Gesi, C., Carmassi, C., Miniati, M., Benvenuti, A., Massimetti, G., & Dell'Osso, L. (2016). Psychotic spectrum symptoms across the lifespan are related to lifetime suicidality among 147 patients with bipolar I or major depressive disorder. Annals of General Psychiatry, 15(1), 15.
Goldberg, J. F., & Harrow, M. (2005). Subjective life satisfaction and objective functional outcome in bipolar and unipolar mood disorders: A longitudinal analysis. Journal of Affective Disorders, 89(1-3), 79-89.
Gournellis, R., Tournikioti, K., Touloumi, G., Thomadakis, C., Michalopoulou, P., Christodoulou, C., … Douzenis, A. (2018). Psychotic (delusional) depression and suicidal attempts: A systematic review and meta-analysis. Acta Psychiatrica Scandinavica, 137(1), 18-29.
Guze, S. B., Jr., W. R., & Clayton, P. J. (1975). The significance of psychotic affective disorders. Archives of General Psychiatry, 32(9), 1147-1150.
Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56-62.
Hartley, S., Barrowclough, C., & Haddock, G. (2013). Anxiety and depression in psychosis: A systematic review of associations with positive psychotic symptoms. Acta Psychiatrica Scandinavica, 128(5), 327-346. https://doi.org/10.1111/acps.12080
Jääskeläinen, E., Juola, T., Korpela, H., Lehtiniemi, H., Nietola, M., Korkeila, J., & Miettunen, J. (2018). Epidemiology of psychotic depression-systematic review and meta-analysis. Psychological Medicine, 48(6), 905-918.
Johnson, J., Horwath, E., & Weissman, M. M. (1991). The validity of major depression with psychotic features based on a community study. Archives of General Psychiatry, 48(12), 1075-1081.
Joiner, T. E., Jr., Steer, R. A., Brown, G., Beck, A. T., Pettit, J. W., & Rudd, M. D. (2003). Worst-point suicidal plans: A dimension of suicidality predictive of past suicide attempts and eventual death by suicide. Behaviour Research and Therapy, 41(12), 1469-1480.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13(2), 261-276.
Konstantakopoulos, G., Masdrakis, V. G., Markianos, M., & Oulis, P. (2013). On the differential diagnosis of anxious from nonanxious major depression by means of the Hamilton Scales. ScientificWorldJournal, 2013, 294516. https://doi.org/10.1155/2013/294516
Lattuada, E., Serretti, A., Cusin, C., Gasperini, M., & Smeraldi, E. (1999). Symptomatologic analysis of psychotic and non-psychotic depression. Journal of Affective Disorders, 54(1-2), 183-187.
Lépine, J.-P., & Briley, M. (2011). The increasing burden of depression. Neuropsychiatric Disease and Treatment, 7(Suppl 1), 3.
Lykouras, L., & Gournellis, R. (2009). Psychotic (delusional) major depression: New vistas. Current Psychiatry Reviews, 5(1), 1-28.
Meyers, B. S. (2014). Psychotic depression: Underrecognized, undertreated-and dangerous. Psychiatric Times, 31(7), 1-4.
Murray, C. J., & Lopez, A. D. (1997). Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study. The Lancet, 349(9064), 1498-1504.
Ohayon, M. M., & Schatzberg, A. F. (2002). Prevalence of depressive episodes with psychotic features in the general population. American Journal of Psychiatry, 159(11), 1855-1861.
Park, S.-C., Lee, H.-Y., Sakong, J.-K., Jun, T.-Y., Lee, M.-S., Kim, J.-M., … Park, Y. C. (2014). Distinctive clinical correlates of psychotic major depression: The CRESCEND study. Psychiatry Investigation, 11(3), 281-289.
Pawlak, J., Dmitrzak-Węglarz, M., Skibińska, M., Szczepankiewicz, A., Leszczyńska-Rodziewicz, A., Rajewska-Rager, A., … Hauser, J. (2013). Suicide attempts and clinical risk factors in patients with bipolar and unipolar affective disorders. General Hospital Psychiatry, 35(4), 427-432.
Perälä, J., Suvisaari, J., Saarni, S. I., Kuoppasalmi, K., Isometsä, E., Pirkola, S., … Kieseppä, T. (2007). Lifetime prevalence of psychotic and bipolar i disorders in a general population. Archives of General Psychiatry, 64(1), 19-28.
Posner, K., Oquendo, M. A., Gould, M., Stanley, B., & Davies, M. (2007). Columbia Classification Algorithm of Suicide Assessment (C-CASA): Classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. American Journal of Psychiatry, 164(7), 1035-1043.
Rothschild, A. J. (2013). Challenges in the treatment of major depressive disorder with psychotic features. Schizophrenia Bulletin, 39(4), 787-796.
Rothschild, A. J., Mulsant, B. H., Meyers, B. S., & Flint, A. J. (2006). Challenges in differentiating and diagnosing psychotic depression. Psychiatric Annals, 36(1).
Schaffer, A., Flint, A. J., Smith, E., Rothschild, A. J., Mulsant, B. H., Szanto, K., … Meyers, B. S. (2008). Correlates of suicidality among patients with psychotic depression. Suicide and Life-Threatening Behavior, 38(4), 403-414.
Smith, B., Fowler, D. G., Freeman, D., Bebbington, P., Bashforth, H., Garety, P., … Kuipers, E. (2006). Emotion and psychosis: Links between depression, self-esteem, negative schematic beliefs and delusions and hallucinations. Schizophrenia Research, 86(1-3), 181-188.
Startup, H., Freeman, D., & Garety, P. A. (2007). Persecutory delusions and catastrophic worry in psychosis: Developing the understanding of delusion distress and persistence. Behaviour Research and Therapy, 45(3), 523-537.
Üstün, T. B., Ayuso-Mateos, J. L., Chatterji, S., Mathers, C., & Murray, C. J. (2004). Global burden of depressive disorders in the year 2000. The British Journal of Psychiatry, 184(5), 386-392.
Verdoux, H., Os, J. V., Maurice-Tison, S., Gay, B., Salamon, R., & Bourgeois, M. L. (1999). Increased occurrence of depression in psychosis-prone subjects: A follow-up study in primary care settings. Comprehensive Psychiatry, 40(6), 462-468.
Wigman, J. T., van Nierop, M., Vollebergh, W. A., Lieb, R., Beesdo-Baum, K., Wittchen, H.-U., & van Os, J. (2012). Evidence that psychotic symptoms are prevalent in disorders of anxiety and depression, impacting on illness onset, risk, and severity-implications for diagnosis and ultra-high risk research. Schizophrenia Bulletin, 38(2), 247-257.
Yung, A. R., Phillips, L. J., Yuen, H. P., & Mcgorry, P. D. (2004). Risk factors for psychosis in an ultra high-risk group: Psychopathology and clinical features. Schizophrenia Research, 67(2), 131-142.
Zalpuri, I., & Rothschild, A. J. (2016). Does psychosis increase the risk of suicide in patients with major depression? A systematic review. Journal of Affective Disorders, 198, 23-31.
Zaninotto, L., Souery, D., Calati, R., Camardese, G., Janiri, L., Montgomery, S., … Mendlewicz, J. (2015). Dimensions of delusions in major depression: Socio-demographic and clinical correlates in an unipolar-bipolar sample. Clinical Psychopharmacology and Neuroscience, 13(1), 48-52.
Zhang, M. (1998). Handbook of rating scales in psychiatry. Changsha, Hunan: Hunan Science and Technology Press.

Auteurs

Yanmei Shen (Y)

Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Department of Psychiatry, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Hunan Key Laboratory of Psychiatry and Mental Health, Mental Health Institute of Central South University, Changsha, Hunan, China.

Ying Wei (Y)

Department of Psychiatry, Changshu Third Hospital of People, Changshu, Jiangshu, China.

Xu-Na Yang (XN)

Department of Psychiatry, Suzhou Psychiatric Hospital, The Affiliated Guangji Hospital of Soochow University, Suzhou, China.

Guangya Zhang (G)

Department of Psychiatry, Suzhou Psychiatric Hospital, The Affiliated Guangji Hospital of Soochow University, Suzhou, China.

Xiangdong Du (X)

Department of Psychiatry, Suzhou Psychiatric Hospital, The Affiliated Guangji Hospital of Soochow University, Suzhou, China.

Qiufang Jia (Q)

Department of Psychiatry, Suzhou Psychiatric Hospital, The Affiliated Guangji Hospital of Soochow University, Suzhou, China.

Xiaomin Zhu (X)

Department of Psychiatry, Suzhou Psychiatric Hospital, The Affiliated Guangji Hospital of Soochow University, Suzhou, China.

Yuejiao Ma (Y)

Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Department of Psychiatry, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Hunan Key Laboratory of Psychiatry and Mental Health, Mental Health Institute of Central South University, Changsha, Hunan, China.

XiaoE Lang (X)

Department of Psychiatry, The First Clinical Medical College, Shanxi Medical University, Taiyuan, Shanxi, China.

Xuerong Luo (X)

Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Department of Psychiatry, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Hunan Key Laboratory of Psychiatry and Mental Health, Mental Health Institute of Central South University, Changsha, Hunan, China.

Xiang Yang Zhang (XY)

Psychological Counseling Center, CAS Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing, China.
Department of Psychology, University of Chinese Academy of Sciences, Beijing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH